Based on our results and the literature, we suggest that controlling the molecular interplay in Subnetwork 1 (i.e., the interplay between HLA class II, CIITA, and CD74) and the enriched pathways provides crucial clinical insights into the mechanism of COVID-19 severity. This evidence concerns the gene CD74 and COVID-19.